[1]胡琦琦,张六一,熊仪,等.癌症患者参与抗肿瘤药物临床试验参与体验的Meta整合[J].军事护理,2023,40(12):104-108.[doi:10.3969/j.issn.2097-1826.2023.12.026]
　HU Qiqi,ZHANG Liuyi,XIONG Yi,et al.Meta-integration of Patients' Participation Experience in Clinical Trials of Antitumor Drugs[J].Nursing Journal Of Chinese People's Laberation Army,2023,40(12):104-108.[doi:10.3969/j.issn.2097-1826.2023.12.026]
点击复制

癌症患者参与抗肿瘤药物临床试验参与体验的Meta整合
分享到：

《军事护理》[ISSN:2097-1826/CN:31-3186/R]

卷:
40
期数:
2023年12期
页码:
104-108
栏目:
循证护理
出版日期:
2023-12-15

文章信息/Info

Title:
Meta-integration of Patients' Participation Experience in Clinical Trials of Antitumor Drugs
文章编号:
2097-1826(2023)12-0104-05
作者:
胡琦琦; 张六一; 熊仪; 吴笑雨; 杨倩; 范瑛瑛
(湖南师范大学 医学院,湖南 长沙 410013)
Author(s):
HU Qiqi; ZHANG Liuyi; XIONG Yi; WU Xiaoyu; YANG Qian; FAN Yingying
(Medical College,Hunan Normal University,Changsha 410013,Hunan Province,China)
关键词:
癌症;  抗肿瘤药物临床试验;  质性研究;  Meta整合
Keywords:
cancer;  clinical trial of antitumor drug;  qualitative research;  Meta-integration
分类号:
R473.73
DOI:
10.3969/j.issn.2097-1826.2023.12.026
文献标志码:
A
摘要:
目的 系统评价癌症患者参与抗肿瘤药物临床试验的参与体验,为临床药物试验的开展提供科学依据。方法 检索PubMed、Web of Science、Embase、Medline、Cochrane Library、CINAHL、中国知网、万方、维普、SinoMed中关于癌症患者参与抗肿瘤药物临床试验参与体验的质性研究。检索时限从建库至2023年2月。采用汇集性整合法进行Meta整合。结果 共纳入17篇文献,提取31个结果,归纳为12个类别,合成4个整合结果:试验参与动机; 试验情绪波动; 试验风险收益感知; 渴望全面支持。结论 癌症患者的抗肿瘤药物临床试验参与意愿受多方因素影响,应提供全面支持,帮助患者科学决策,改善参与体验。
Abstract:
Objective To systematically evaluate the experience of cancer patients'participation in clinical trials of antitumor drugs,and provide scientific basis for the development of these trials.Methods Qualitative studies on the experience of patients participating in clinical trials of antitumor drugs in PubMed,Web of Science,Embase,Medline,Cochrane Library,CINAHL,CNKI,Wanfang,VIP and SinoMed were searched from the time of establishment to February 2023.Meta-integration was carried out by aggregating integration method.Results A total of 17 articles were included,31 results were extracted,and then were summarized into 12 categories,while 4 integrated results were synthesized:motivation for participation in trials; mood fluctuation in trials; risk-benefit perception in trials; eagerness for full support.Conclusions The willingness of cancer patients to participate in clinical trials of antitumor drugs is influenced by many factors,so comprehensive support should be provided to help them make scientific decisions and improve their experience in participation.

参考文献/References:

[1] 石远凯,孙燕.中国抗肿瘤新药临床试验60年发展历程和主要成果(1960—2020)[J].中华肿瘤杂志,2021,43(6):11.
[2] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3] 唐乐,姜时雨,秦燕,等.抗肿瘤新药Ⅰ期临床试验受试者对临床试验的认知和满意度调查[J].中国肿瘤临床,2022,49(7):345-351.
[4] 吴大维,黄慧瑶,唐玉,等.2020年中国肿瘤药物临床试验进展[J].中华肿瘤杂志,2021,43(2):218-223.
[5] 卓玲.临床试验中受试者参与度及依从性的影响因素分析[D].南昌:南昌大学,2022.
[6] THE JOANNA BRIGGS INSTITUTE.Criticl appraisal checklist for qualitative research[EB/OL].[2020-02-29].https://joanna-briggs.org/ebp/critical appraisal tools.
[7] VILJOEN B,HOFMAN M S,CHAMBER S K,et al.Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer:a nested,qualitative longitudinal study[J/OL].[2023-04-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645653/.DOI:10.1371/journal.pone.0276063.
[8] 邢淑君,于玲,陈鹤方,等.肿瘤患者在新辅助免疫治疗临床试验中的角色感知及体验的质性研究[J].护理学报,2022,29(21):6-10.
[9] GREGERSEN T,BIRKELUND R,WOLDERSLUND M,et al.Patients' experiences of the decision-making process for clinical trial participation[J].Nurs Health Sci,2022,24(1):65-72.
[10]VAN GURP J L P,VAN LENT L G G,STLEL N,et al.Core values of patients with advanced cancer considering participation in an early-phase clinical trial:a qualitative study[J].Support Care Cancer,2022,30(9):7605-7613.
[11]SAWYER C,PRESTON L,TAYLOR S,et al.Oncology patients' experiences in experimental medicine cancer trials: a qualitative study[J/OL].[2023-04-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493921/.DOI:10.1136/bmjopen-2020-047813.
[12]祁佳燕,吕宏英.卵巢癌晚期患者参与药物临床试验期心理体验质性研究[J].护理与康复,2021,20(2):96-99.
[13]ULRICH C M,KNAFL K,FOXWELL A M,et al.Experiences of patients after withdrawal from cancer clinical trials[J/OL].[2023-04-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356063/.DOI:10.1001/jamanetworkopen.2021.20052.
[14]郭彩利,王晓宁,樊婷,等.CAR-T细胞临床试验治疗血液系统肿瘤患者心理体验的质性研究[J].中国医学伦理学,2019,32(5):623-626.
[15]DELLSON P,NILSSON K,JERNSTROM H,et al.Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study[J/OL].[2023-04-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162882/.DOI:10.1186/s13063-018-2916-9.
[16]INGERSGARRD M V,TULSTRUP M,SCHMIEGELOW K,et al.A qualitative study of decision-making on phase Ⅲ randomized clinical trial participation in paediatric oncology:adolescents' and parents' perspectives and preferences[J].J Adv Nurs,2018,74(1):110-118.
[17]REEDER-HAYES K E,ROBERTS M C,HENDERSON G E,et al.Informed consent and decision making among participants in novel-design phase Ⅰ oncology trials[J].J Oncol Pract,2017,13(10):e863-e873.
[18]RIDGEWAY J L,ASIEDU G B,CARROLL K,et al.Patient and family member perspectives on searching for cancer clinical trials: a qualitative interview study[J].Patient Educ Couns,2017,100(2):349-354.
[19]MALAN T,MOODLEY K.Phase 3 oncology clinical trials in South Africa:experimentation or therapeutic misconception?[J].J Empir Res Hum Res Ethics,2016,11(1):47-56.
[20]BREDART A,BODSON S,TOURNEAU C,et al.Patients' perceived tolerance of side effects in phase I cancer clinical trials:a qualitative study[J/OL].[2023-04-01].https://onlinelibrary.wiley.com/doi/10.1111/ecc.12596.DOI:10.1111/ecc.12596.
[21]GODSKESEN T,NYGREN P,NORGIN K,et al.Phase 1 clinical trials in end-stage cancer:patient understanding of trial premises and motives for participation[J].Support Care Cancer,2013,21(11):3137-3142.
[22]QUINN G P,KOSKAN A,WELLS K J,et al.Cancer patients' fears related to clinical trial participation: a qualitative study[J].J Cancer Educ,2012,27(2):257-262.
[23]WOOTTEN A C,ABBOTT J M,SIDDONS H M,et al.A qualitative assessment of the experience of participating in a cancer-related clinical trial[J].Support Care Cancer,2011,19(1):49-55.
[24]邢淑君,陈鹤方,胡梦蝶,等.肿瘤患者参与药物临床试验现状及影响因素研究[J].中国新药杂志,2022,31(12):1201-1208.
[25]肖霖,黄重梅,方庆虹,等.基于扎根理论的癌症患者关系性自主治疗决策行为理论框架的构建研究[J].军事护理,2022,39(7):66-69.
[26]康斯寒,陆宇晗,庞冬,等.肿瘤临床试验受试者知情同意质量的研究进展[J].中国护理管理,2023,23(9):1431-1436.
[27]徐萍,徐涛,周旋,等.新形势下药物临床试验机构管理实践与探索[J].中国医院,2023,27(8):92-94.

相似文献/References:

[1]许嘉硕,季红娟,李佳镁,等.癌症患者重返工作适应体验及应对资源的扎根理论研究[J].军事护理,2021,38(02):1.[doi:10.3969/j.issn.1008-9993.2021.02.001]
　XU Jiashuo,JI Hongjuan,LI Jiamei,et al.Adaptation Experience and Coping Resources of Cancer Patients Returning to Work: A Grounded Theory Study[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(12):1.[doi:10.3969/j.issn.1008-9993.2021.02.001]
[2]信博,赵秋利,王楠楠.癌症高危人群癌症风险感知的研究进展[J].军事护理,2021,38(03):41.[doi:10.3969/j.issn.1008-9993.2021.03.010]
[3]高娅鑫,屈清荣,王碧轩,等.重返工作自我效能问卷的汉化及其在癌症患者中的信效度检验[J].军事护理,2021,38(07):52.[doi:10.3969/j.issn.1008-9993.2021.07.013]
　GAO Yaxin,QU Qingrong,WANG Bixuan,et al.Chinese Translation of the Return-To-Work Self-Efficacy Questionnaire in Cancer Patients and Its Reliability and Validity Test[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(12):52.[doi:10.3969/j.issn.1008-9993.2021.07.013]
[4]周帅,江锦芳,张玲,等.不同运动疗法对癌症患者癌因性疲乏干预效果的网状Meta分析[J].军事护理,2021,38(08):65.[doi:10.3969/j.issn.1008-9993.2021.08.017]
　ZHOU Shuai,JIANG Jinfang,ZHANG Ling,et al.Different Exercise Therapies in Patients with Cancer-related Fatigue: A Network Meta-Analysis[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(12):65.[doi:10.3969/j.issn.1008-9993.2021.08.017]
[5]曾庆威,罗梦娜,王菲菲,等.青少年癌症幸存者重返校园体验与期待的质性研究[J].军事护理,2021,38(12):46.[doi:10.3969/j.issn.1008-9993.2021.12.012]
　ZENG Qingwei,LUO Mengna,WANG Feifei,et al.Return-To-School Experience and Expectations of Adolescent Cancer Survivors:A Qualitative Study[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(12):46.[doi:10.3969/j.issn.1008-9993.2021.12.012]
[6]陈娟娟,李惠萍,张婷,等.癌症患者及其配偶二元关系的研究进展[J].军事护理,2021,38(12):79.[doi:10.3969/j.issn.1008-9993.2021.12.021]
[7]刘贺,郑蔚,苏闪闪,等.癌症患者夫妻疾病沟通评估工具的研究进展[J].军事护理,2022,39(03):82.[doi:10.3969/j.issn.1008-9993.2022.03.020]
[8]胡扬帆,彭雪兰,赵娟娟.癌症生命末期照护家属决策自我效能量表的汉化和信效度评价[J].军事护理,2022,39(04):42.[doi:10.3969/j.issn.1008-9993.2022.04.011]
　HU Yangfan,PENG Xuelan,ZHAO Juanjuan.Chinese Version of Family Decision-making Self-efficacy Scale Regarding End-of-life Care Decisions of Cancer Patients: Reliability and Validity[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(12):42.[doi:10.3969/j.issn.1008-9993.2022.04.011]
[9]李佳镁,郭瑜洁,陈思琪,等.基于CiteSpace的癌症职业康复研究热点分析[J].军事护理,2022,39(06):60.[doi:10.3969/j.issn.1008-9993.2022.06.015]
　LI Jiamei,GUO Yujie,CHEN Siqi,et al.Hotspots of Cancer Occupational Rehabilitation Research Based on CiteSpace[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(12):60.[doi:10.3969/j.issn.1008-9993.2022.06.015]
[10]肖霖,黄重梅,方庆虹,等.基于扎根理论的癌症患者关系性自主治疗决策行为理论框架的构建研究[J].军事护理,2022,39(07):66.[doi:10.3969/j.issn.2097-1826.2022.07.017]
　XIAO Lin,HUANG Chongmei,FANG Qinghong,et al.Construction of the Theoretical Framework of Relational Autonomy Treatment Decision-Making Behaviors Among Cancer Patients: A Grounded Theory Study[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(12):66.[doi:10.3969/j.issn.2097-1826.2022.07.017]

备注/Memo

备注/Memo:
【收稿日期】2023-04-12【修回日期】2023-11-13
【作者简介】胡琦琦,硕士在读,护士,电话:0731-88912416
【通信作者】张六一,电话:0731-88912416
更新日期/Last Update: 2023-12-15